Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 88Colonic Neoplasms 30Colonic Polyps 20Adenoma 19Polyps 8Neoplasms 8Colorectal Neoplasms, Hereditary Nonpolyposis 6Adenomatous Polyps 6Disease 5Rectal Neoplasms 4Pain 4Gastrointestinal Neoplasms 4Stomach Neoplasms 2Peptic Ulcer 2Pancreatic Neoplasms 2Liver Cirrhosis 2Intestinal Neoplasms 2Intestinal Diseases 2Inflammatory Bowel Diseases 2Gastritis, Atrophic 2Digestive System Diseases 2Colitis, Ulcerative 2Anus Neoplasms 2Adenomatous Polyposis Coli 2Turcot syndrome 1Tuberculosis 1Triple Negative Breast Neoplasms 1Signs and Symptoms, Digestive 1Recurrence 1Rectal Diseases 1

Interventions

Endoscopy 2Eicosapentaenoic Acid 2pegvisomant 1alovudine 1Tirzepatide 1Restraint, Physical 1Microspheres 1Metformin 1Colonoscopy 1Clinical Chemistry Tests 1Cholecalciferol 1Calcitriol 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperplasia × Colonoscopy × Clear all
NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡